Interaction Between Chlorhexidine and Fluoride

October 12, 2016 updated by: Oscar Villa, University of Oslo

Interaction Chlorhexidine-fluoride - a 4-day and 6-week Randomised Clinical Mouthrinse Study

The aim of the present study was to study if there are interactions and reduced clinical effect between chlorhexidine and fluoride when they are combined in the same mouthrinse.

Study Overview

Detailed Description

The investigation assessed the clinical effect of a mouthrinse containing chlorhexidine (CHX) and sodium fluoride (NaF) during a 4-day period of non-brushing and a 6-week period of brushing. Two studies were designed as double-blind, randomized, cross-over clinical trials. In study I, 16 healthy subjects rinsed twice daily for 1 min during 4 days of no tooth brushing with four mouthrinse solutions: 1) 0.12% CHX + 0.2% NaF, 2) 0.2% NaF, 3) 0.12% CHX, and 4) placebo. In study 2, 16 healthy subjects rinsed with the same four solutions twice daily after tooth brushing during a 6-week period. Primary outcomes were plaque formation and gingivitis. Secondary outcomes were fluoride retention and microbiological parameters in plaque and saliva (total bacterial counts and mutans streptococci, lactobacilli and streptococci sanguinis counts). One way analyses of variance with post hoc Student-Newman-Keul´s statistical test was performed for comparisons between mouthrinses. Intragroup changes over time were analyzed with a paired t-test.

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Phase 4

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male and female subjects, age 18-35 years
  • Good general health
  • No signs of periodontitis and caries
  • A minimum of 24 teeth with no extensive restorations
  • No current or planned dental treatment during the trial periods.

Exclusion Criteria:

  • Antibiotic treatment within 1 month prior to the start of the trial
  • Current medication with anti-inflammatory drugs
  • Use of antiseptic mouthrinses
  • Smokers and snuff user
  • Use of chewing gums

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 0.12 % chlorhexidine + 0.2 % NaF mouthrinse
A mouthrinse combining chlorhexidine and NaF

In study I, subjects were asked to refrain from tooth brushing and interdental cleaning and rinse with 10 ml of the assigned test solution for one minute, twice daily (morning and evening) during 4 days.

In study II, subjects were asked to rinse with 10ml of the assigned test solution twice daily after tooth brushing during a 6-week period.

Other Names:
  • Chlorhexidine + NaF mouthwash
Active Comparator: 0.2 % NaF mouthrinse
A mouthrinse containing NaF

In study I, subjects were asked to refrain from tooth brushing and interdental cleaning and rinse with 10 ml of the assigned test solution for one minute, twice daily (morning and evening) during 4 days.

In study II, subjects were asked to rinse with 10ml of the assigned test solution twice daily after tooth brushing during a 6-week period.

Other Names:
  • NaF mouthwash
Active Comparator: 0.12% chlorhexidine mouthrinse
A mouthrinse containing chlorhexidine

In study I, subjects were asked to refrain from tooth brushing and interdental cleaning and rinse with 10 ml of the assigned test solution for one minute, twice daily (morning and evening) during 4 days.

In study II, subjects were asked to rinse with 10ml of the assigned test solution twice daily after tooth brushing during a 6-week period.

Other Names:
  • Chlorhexidine mouthwash
Placebo Comparator: Placebo mouthrinse
A mouthrinse containing all basic ingredients as the other three mouth rinses compared but without chlorhexidine and fluoride

Contained all basic ingredients as the other three mouthrinses but no chlorhexidine and no NaF. In study I, subjects were asked to refrain from tooth brushing and interdental cleaning and rinse with 10 ml of the assigned test solution for one minute, twice daily (morning and evening) during 4 days.

In study II, subjects were asked to rinse with 10ml of the assigned solution twice daily after tooth brushing during a 6-week period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Plaque index
Time Frame: Baseline
Baseline
Plaque index
Time Frame: Day 4
Day 4
Plaque index
Time Frame: Day 42
Day 42
Gingivitis index
Time Frame: Baseline
Baseline
Gingivitis index
Time Frame: Day 42
Day 42

Secondary Outcome Measures

Outcome Measure
Time Frame
Mutans streptococci counts in dental plaque and saliva
Time Frame: Day 0
Day 0
Mutans streptococci counts in dental plaque and saliva
Time Frame: Day 4
Day 4
Streptococcus sanguis counts in dental plaque and saliva
Time Frame: Day 42
Day 42
Lactobacilli counts in dental plaque and saliva
Time Frame: Day 0
Day 0
Lactobacilli counts in dental plaque and saliva
Time Frame: Day 4
Day 4
Lactobacilli counts in dental plaque and saliva
Time Frame: Day 42
Day 42
Streptococcus sanguinis counts in dental plaque and saliva
Time Frame: Day 0
Day 0
Streptococcus sanguinis counts in dental plaque and saliva
Time Frame: Day 4
Day 4
Streptococcus sanguinis counts in dental plaque and saliva
Time Frame: Day 42
Day 42
Total bacterial counts in dental plaque and saliva
Time Frame: Day 0
Day 0
Total bacterial counts in dental plaque and saliva
Time Frame: Day 4
Day 4
Total bacterial counts in dental plaque and saliva
Time Frame: Day 42
Day 42

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Per Ramberg, Professor, Göteborg University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2009

Primary Completion (Actual)

December 1, 2011

Study Completion (Actual)

February 1, 2012

Study Registration Dates

First Submitted

October 10, 2016

First Submitted That Met QC Criteria

October 12, 2016

First Posted (Estimate)

October 17, 2016

Study Record Updates

Last Update Posted (Estimate)

October 17, 2016

Last Update Submitted That Met QC Criteria

October 12, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Caries

Clinical Trials on 0.12 % chlorhexidine + 0.2 % NaF mouthrinse

3
Subscribe